Cargando…
Shifting emphasis from pharmacogenomics to theragnostics
What will be the role of theragnostic patents in upstream and downstream biomarker research?
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group US
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096916/ https://www.ncbi.nlm.nih.gov/pubmed/16900136 http://dx.doi.org/10.1038/nbt0806-942 |